Compare Samcro Hyosung Adilestari Tbk. (ACRO) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Samcro Hyosung Adilestari Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Samcro Hyosung Adilestari Tbk. trades at Rp63 (market cap 218.57B, 5.19M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Samcro Hyosung Adilestari Tbk. is more actively traded (5.19M versus 41.7K). Which is the better fit depends on your goals.
| ACRO | DGNS | |
|---|---|---|
Market Cap | 218.57B | 316.25B |
Volume | 5.19M | 41.7K |
Lot | 51.94K | 417 |
Turnover | 327.46M | 9.66M |
Average Price | 63.04 | 231.65 |
Value | 327.46M | 9.66M |
Indicative Equilibrium Price | 63 | 230 |
Indicative Equilibrium Volume | 957 | 2.4K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Samcro Hyosung Adilestari Tbk.
PT Samcro Hyosung Adilestari Tbk (The Company) was established on Republic of Indonesia based on Deed of Establishment No. 265 dated July 21, 1989 by Yudo Paripurno, S.H., Notary in Jakarta.
Read more on ACRO →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
